But the FDA and the Centers for Disease Control and Prevention (CDC) released a safety notice on May 9 recommending that adults over 60 years old pause use of the vaccine due to fatal complications.

The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.

US health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible side effects.

The U.S. government advised American travelers age 60 and older not get a chikungunya vaccine as it investigates possible side effects. The Centers for Disease Control and Prevention and the Food and ...

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in ...

An outbreak of a serious infection brought back to the UK by holidaymakers has led to two new vaccines being approved in the ...

In order to ensure the most effective transfer of high levels of antibodies, you must administer the vaccine at the proper time/s. Pregnant females begin to form colostrum by pulling antibodies from ...